Gland Pharma Ltd.

₹1978.5

Gland Pharma Ltd.

Add Alert
Add Watchlist

₹1978.5

₹1978.5

-86.3 (-4.18%) - 2 Aug 2025 04:25 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹ 32,597 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 29.91
P/B Ratio 3.34
Enterprise Value -
ROE % 11.62
RSI Value 42.08
EMA 50 1841.27
EMA 200 1709.02
Market Cap. ₹ 32,597 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 46.66
P/B Ratio 3.56
Enterprise Value -
ROE % 7.82
RSI Value 42.08
EMA 50 1841.27
EMA 200 1709.02

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.